AUCATZYL
Obecabtagene autoleucel · KIT · Autolus Inc.
Obecabtagene autoleucel (Aucatzyl) is a CAR-T cell therapy used to treat certain types of blood cancers by genetically modifying a patient's own immune cells to fight cancer. This treatment is administered through a specialized medical procedure and requires careful medical supervision.
Key Facts
- Brand Name
- AUCATZYL
- Generic Name
- Obecabtagene autoleucel
- NDC Code (Product)
83047-410- Manufacturer
- Autolus Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125813
- Marketing Start
- 11/08/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is AUCATZYL used for?
Obecabtagene autoleucel (Aucatzyl) is a CAR-T cell therapy used to treat certain types of blood cancers by genetically modifying a patient's own immune cells to fight cancer. This treatment is administered through a specialized medical procedure and requires careful medical supervision.
Is AUCATZYL a controlled substance?
AUCATZYL is not classified as a controlled substance by the DEA.
What is the generic name for AUCATZYL?
The generic name for AUCATZYL is Obecabtagene autoleucel. There are no other listed brand versions of Obecabtagene autoleucel.
What is the NDC code for AUCATZYL ?
The NDC (National Drug Code) for AUCATZYL is 83047-410, listed by Autolus Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)